Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04546620
Title Acalabrutinib in Combination With R-CHOP for Previously Untreated Diffuse Large B-cell Lymphoma (DLBCL) (REMoDL-A)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Southampton NHS Foundation Trust
Indications

B-cell lymphoma

diffuse large B-cell lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + Vincristine Sulfate

Acalabrutinib + Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + Vincristine Sulfate

Age Groups: senior | child | adult
Covered Countries

Facility Status City State Zip Country Details
Colchester General Hospital Recruiting Colchester Essex United Kingdom Details
East Kent Hospitals NHS Foundation Trust Recruiting Canterbury Kent United Kingdom Details
Nottingham City Hospital Recruiting Nottingham United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field